Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc.

Bullboard Posts

Comment by TechnicalBuyon Jan 28, 2012 8:57am

218 Views

Post# 19460955

RE: RE: biOasis like Immunogen

jd, I think a take-over is a possibility, but we are far more likely to see an exclusive licensing deal first. This would only be fair to us as shareholders because a premature take-over might rob us of significant upside potential.

I found this article to be very useful in looking at valuations of companies that are similar to Bioasis. Of particular interest is Immunogen's $1 bn valuation based mostly on it's 'air to the throne' status for Herceptin....note that at a $1, biOasis' market cap is barely over $30 M. Even with the sp at $3 we are only at $100 mcap....